Elucidating the glycan-binding specificity and structure of Cucumis melo agglutinin, a new R-type lectin

• Jon Lundstrøm,
• Emilie Gillon,
• Valérie Chazalet,
• Nicole Kerekes,
• Antonio Di Maio,
• Ten Feizi,
• Yan Liu,
• Annabelle Varrot and
• Daniel Bojar

Beilstein J. Org. Chem. 2024, 20, 306–320, doi:10.3762/bjoc.20.31

• ”), in particular chondroitin sulfate (CS) C and A. Given the preference for terminal binding epitopes described above, the question naturally arose how the binding to these longer-chain glycans works. On the ICL array, CS sequences are typically capped with 4,5-unsaturated hexuronic acid derivatives on

• , containing Fucα1-2Gal or GalNAc epitopes, were on average not bound by RCA1 (the exception being sequences in which there was an additional free Galβ terminus). Similarly, most chondroitin sulfate probes were not bound by RCA1. This gives rise to the conclusion that CMA1 does not merely tolerate but rather

• galactose that is preferentially presented in a β-configuration, enables it to bind to a range of biologically relevant epitopes, such as LacdiNAc, Sda, blood group H, and chondroitin sulfate motifs. Further, the inhibition of binding by the presence of Lewis antigen motifs additionally narrows it binding

Studying specificity in protein–glycosaminoglycan recognition with umbrella sampling

• Mateusz Marcisz,
• Sebastian Anila,
• Margrethe Gaardløs,
• Martin Zacharias and
• Sergey A. Samsonov

Beilstein J. Org. Chem. 2023, 19, 1933–1946, doi:10.3762/bjoc.19.144

• essential to explain their biological functions. In this study, the umbrella sampling (US) approach is used to pull away a GAG ligand from the binding site and then pull it back in. We analyze the binding interactions between GAGs of three types (heparin, desulfated heparan sulfate, and chondroitin sulfate

• (HA), chondroitin sulfate (CS), dermatan sulfate (DS), and keratan sulfate (KS). The structural and functional diversities of GAGs are regulated by their sequence, size of the chains, degree of sulfation, and the ability to bind proteins [1][18][19][20][21]. This structural diversity of GAGs

• interactions is important in understanding the nature of the interactions and the stability of the binding pose, including the scenario when several co-existing binding poses are identified. We analyze the binding interactions between the GAGs heparin, heparan sulfate, and chondroitin sulfate, and the proteins

Progress and challenges in the synthesis of sequence controlled polysaccharides

• Giulio Fittolani,
• Theodore Tyrikos-Ergas,
• Denisa Vargová,
• Manishkumar A. Chaube and
• Martina Delbianco

Beilstein J. Org. Chem. 2021, 17, 1981–2025, doi:10.3762/bjoc.17.129

A systems-based framework to computationally describe putative transcription factors and signaling pathways regulating glycan biosynthesis

• Theodore Groth,
• Rudiyanto Gunawan and
• Sriram Neelamegham

Beilstein J. Org. Chem. 2021, 17, 1712–1724, doi:10.3762/bjoc.17.119

• core 3 and core 4 glycans can occur during disease, and thus this classification includes core 3-forming B3GNT6 and core 4-forming GCNT3. Other O-glycan core types are rare in nature. 8) Chondroitin sulfate and heparan sulfate initiation: Chondroitin and heparan sulfate glycosaminoglycans all have a

• adds glucuronic acid to the terminal galactose. Also involved in the formation of this core is FAM20B, a kinase that 2-O-phosphorylates xylose. At this point, the addition of GalNAc to GlcA by CSGALNACT1 and 2 results in the initiation of chondroitin sulfate chains. The attachment of GlcNAc by EXTL3 to

• the same GlcA results in heparan sulfates. 9) Chondroitin sulfate and dermatan sulfate extension: Chondroitin sulfates and dermatan sulfates are extended via the addition of GalNAc-GlcA repeat units. This is catalyzed by CSGALNACT1, which is better suited for the initial GalNAc attachment, followed by

Selected peptide-based fluorescent probes for biological applications

• Debabrata Maity

Beilstein J. Org. Chem. 2020, 16, 2971–2982, doi:10.3762/bjoc.16.247

• serum albumin. Other biomolecules such as adenosine, adenosine monophosphate, adenosine triphosphate, phosphate, pyrophosphate, glucose, heparin, hyaluronic acid and chondroitin sulfate, and amino acids containing two carboxylates (glutamic acid and aspartic acid) have not increased the fluorescence

Unexpected loss of stereoselectivity in glycosylation reactions during the synthesis of chondroitin sulfate oligosaccharides

• Teresa Mena-Barragán,
• José L. de Paz and
• Pedro M. Nieto

Beilstein J. Org. Chem. 2019, 15, 137–144, doi:10.3762/bjoc.15.14

• -assisted synthesis of chondroitin sulfate (CS) oligosaccharides. Following this approach, a CS tetrasaccharide was prepared. However, in contrast to our previous results, a significant loss of β-selectivity was observed in [2 + 2] glycosylations involving N-trifluoroacetyl-protected D-galactosamine donors

• substitution pattern of GlcA units for the efficient synthesis of CS oligomers. Keywords: carbohydrate chemistry; chondroitin sulfate; glycosylation; oligosaccharide synthesis; stereoselectivity; Introduction Chondroitin sulfate (CS) is a highly heterogeneous polysaccharide, constituted by the repetition of

Detonation nanodiamonds biofunctionalization and immobilization to titanium alloy surfaces as first steps towards medical application

• Juliana P. L. Gonçalves,
• Afnan Q. Shaikh,
• Manuela Reitzig,
• Daria A. Kovalenko,
• Jan Michael,
• René Beutner,
• Gianaurelio Cuniberti,
• Dieter Scharnweber and
• Jörg Opitz

Beilstein J. Org. Chem. 2014, 10, 2765–2773, doi:10.3762/bjoc.10.293

• ]. Others worked on collagenous matrix coatings on titanium implants modified with decorin and chondroitin sulfate that enhanced osteoblast adhesion and increased expression of osteopontin (a bone-specific marker) [19]. Immobilization of biologically active molecules, by using tripartite molecules (linker